These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36856225)

  • 21. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progression of LDLR mutations in Chinese Familial hypercholesterolemia].
    Dai YF; Sun LY; Zhang XB; Wang LY
    Yi Chuan; 2011 Jan; 33(1):1-8. PubMed ID: 21377952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.
    Alnouri F; Al-Allaf FA; Athar M; Al-Rasadi K; Alammari D; Alanazi M; Abduljaleel Z; Awan Z; Bouazzaoui A; Dairi G; Elbjeirami WM; Karra H; Kinsara AJ; Taher MM
    Curr Vasc Pharmacol; 2022; 20(4):361-369. PubMed ID: 35249492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.
    Rodríguez-Jiménez C; Pernía O; Mostaza J; Rodríguez-Antolín C; de Dios García-Díaz J; Alonso-Cerezo C; García-Polo I; Blanco A; Lahoz C; Arrieta F; Beltrán L; Díaz de Bustamante A; Garzón-Lorenzo L; Álvarez-Sala LA; Asenjo Á; Ibáñez de Cáceres I; Rodríguez-Nóvoa S
    Hum Mutat; 2019 Aug; 40(8):1181-1190. PubMed ID: 31106925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
    Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
    Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
    Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
    J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
    Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z
    J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.
    Benito-Vicente A; Uribe KB; Jebari S; Galicia-Garcia U; Ostolaza H; Martin C
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
    Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of gene- and cell-based therapies for familial hypercholesterolemia.
    Hajighasemi S; Mahdavi Gorabi A; Bianconi V; Pirro M; Banach M; Ahmadi Tafti H; Reiner Ž; Sahebkar A
    Pharmacol Res; 2019 May; 143():119-132. PubMed ID: 30910740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
    Reddy LL; Shah SAV; Ashavaid TF
    Indian Heart J; 2022; 74(1):1-6. PubMed ID: 34875256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches.
    Taheri F; Taghizadeh E; Baniamerian F; Rostami D; Rozeian A; Mohammad Gheibi Hayat S; Jamialahmadi T; Reiner Ž; Sahebkar A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1018-1028. PubMed ID: 35532248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for familial hypercholesterolemia.
    Van Craeyveld E; Jacobs F; Gordts SC; De Geest B
    Curr Pharm Des; 2011; 17(24):2575-91. PubMed ID: 21774774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.